Company overview
Miltenyi Biotec provides research- and clinical-grade products for sample preparation, cell separation, flow cytometry, and cell culture. Miltenyi Bioindustry, its CDMO division, offers services for developing and manufacturing cell and gene therapies, including lentiviral vectors, from preclinical to commercial scale. The company supports immunotherapy, regenerative medicine, and graft engineering with automated systems like CliniMACS Prodigy.
Miltenyi Biotec is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include miltenyi biotec, cell and gene therapy, cdmo services, clinimacs prodigy, flow cytometry, cell separation.
Industry categories: Life Science Reagents, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.miltenyibiotec.com
- Categories
- Life Science Reagents, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- miltenyi biotec, cell and gene therapy, cdmo services, clinimacs prodigy, flow cytometry, cell separation
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What CDMO capabilities does Miltenyi Biotec offer for cell and gene therapy?
- Miltenyi Bioindustry provides end-to-end CDMO services for cell-based therapies and lentiviral vectors, from preclinical development to commercial manufacturing, using automated systems like CliniMACS Prodigy with capacity for over 1000 batches per year at sites including San Jose.
- What products does Miltenyi Biotec provide for research and clinical applications?
- They offer research- and clinical-grade products for sample preparation, cell separation, flow cytometry, cell culture, antibodies for multiple applications, and spatial biology tools.
- What are Miltenyi Biotec's global manufacturing sites and regulatory compliance?
- Miltenyi operates five global Bioindustry sites, including a Cell Therapy Center of Excellence in San Jose, California, with GMP-compliant facilities supporting automated cell processing for clinical and commercial therapies.
Related editorial coverage
- ASGCT Annual Meeting 2026: Live Event Coverage and Key Insights
- Fierce Biotech Week: Key Takeaways and Emerging Trends
- ASGCT 2024: Gene Therapy Advancements Day 1 Roundup
- ASGCT: Manufacturing Innovations Take Center Stage
Explore lab tools and QA/QC resources for R&D teams.
